![]() |
Name |
Cytosporin B
|
Molecular Formula | C17H27ClO5 | |
IUPAC Name* |
(3R,4aS,5R,6S,8aR)-5-chloro-3,4a,6-trihydroxy-2,2-dimethyl-7-pentyl-4,5,6,8a-tetrahydro-3H-chromene-8-carbaldehyde
|
|
SMILES |
CCCCCC1=C([C@@H]2[C@@](C[C@H](C(O2)(C)C)O)([C@@H]([C@H]1O)Cl)O)C=O
|
|
InChI |
InChI=1S/C17H27ClO5/c1-4-5-6-7-10-11(9-19)15-17(22,14(18)13(10)21)8-12(20)16(2,3)23-15/h9,12-15,20-22H,4-8H2,1-3H3/t12-,13+,14-,15-,17-/m1/s1
|
|
InChIKey |
YSYMCIKNYHKBHZ-JRBZFYFNSA-N
|
|
Synonyms |
Cytosporin B; (3R,4As,5R,6S,8aR)-5-chloro-3,4a,6-trihydroxy-2,2-dimethyl-7-pentyl-4,5,6,8a-tetrahydro-3H-chromene-8-carbaldehyde
|
|
CAS | NA | |
PubChem CID | 10760039 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 346.8 | ALogp: | 0.8 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 23 | QED Weighted: | 0.404 |
Caco-2 Permeability: | -4.913 | MDCK Permeability: | 0.00003280 |
Pgp-inhibitor: | 0.038 | Pgp-substrate: | 0.942 |
Human Intestinal Absorption (HIA): | 0.31 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.007 |
Blood-Brain-Barrier Penetration (BBB): | 0.592 | Plasma Protein Binding (PPB): | 80.88% |
Volume Distribution (VD): | 1.666 | Fu: | 16.64% |
CYP1A2-inhibitor: | 0.031 | CYP1A2-substrate: | 0.134 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.779 |
CYP2C9-inhibitor: | 0.018 | CYP2C9-substrate: | 0.103 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.141 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.224 |
Clearance (CL): | 6.645 | Half-life (T1/2): | 0.339 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.357 |
Drug-inuced Liver Injury (DILI): | 0.069 | AMES Toxicity: | 0.844 |
Rat Oral Acute Toxicity: | 0.729 | Maximum Recommended Daily Dose: | 0.971 |
Skin Sensitization: | 0.719 | Carcinogencity: | 0.683 |
Eye Corrosion: | 0.316 | Eye Irritation: | 0.363 |
Respiratory Toxicity: | 0.98 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003183 | ![]() |
0.704 | D0P1FO | ![]() |
0.263 | ||
ENC004325 | ![]() |
0.542 | D0HR8Z | ![]() |
0.232 | ||
ENC001996 | ![]() |
0.532 | D04VIS | ![]() |
0.229 | ||
ENC004326 | ![]() |
0.494 | D00HCQ | ![]() |
0.229 | ||
ENC002511 | ![]() |
0.494 | D0L7AS | ![]() |
0.227 | ||
ENC004324 | ![]() |
0.482 | D0V0IX | ![]() |
0.224 | ||
ENC003663 | ![]() |
0.452 | D03SXE | ![]() |
0.224 | ||
ENC004331 | ![]() |
0.427 | D0O1UZ | ![]() |
0.216 | ||
ENC004330 | ![]() |
0.421 | D04QNO | ![]() |
0.215 | ||
ENC004329 | ![]() |
0.418 | D0Y7IU | ![]() |
0.215 |